Table 4.
Univariate and multivariate Cox analyses in the Stiftung Tumorbank Basel data set (n = 317)
Factor | Univariate metastasis-free survival | Multivariate metastasis-free survival | ||
Hazard ratio (95% confidence interval) | P value | Hazard ratio (95% confidence interval) | P value | |
E2F1 (>p30 versus ≤ p30) | 4.27 (1.83–9.96) | 0.001 | 2.95 (1.10–7.93) | 0.032 |
Grade (3 versus 1 + 2) | 2.03 (1.17–3.51) | 0.011 | 1.56 (0.77–3.14) | 0.213 |
Estrogen receptor status (positive versus negative) | 0.64 (0.37–1.12) | 0.120 | 1.21 (0.56–2.61) | 0.625 |
ERBB2 status (positive versus negative) | 1.69 (0.98–2.92) | 0.058 | 1.41 (0.70–2.81) | 0.335 |
pN (>3 nodes versus ≤ 3 nodes) | 3.14 (1.76–5.61) | <0.001 | 2.36 (1.14–4.88) | 0.021 |
Size (>2 cm versus ≤ 2 cm) | 1.95 (1.05–3.62) | 0.036 | 1.19 (0.58–2.43) | 0.641 |
Age (≤ 40 years versus >40 years) | 0.30 (0.15–0.59) | 0.001 | 0.59 (0.24–1.43) | 0.246 |
Chemotherapy | 2.65 (1.54–4.55) | <0.001 | 1.27 (0.45–3.59) | 0.654 |
Hormone therapy | 0.50 (0.28–0.88) | 0.017 | 0.76 (0.27–2.17) | 0.605 |
70-gene signature (poor versus good prognosis) | Not available | Not available | Not available | Not available |